NCT03705195View on ClinicalTrials.gov

Study of Sulphonylurea Synergy With Incretins

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 3, 2018

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Gliclazide

Low dose liquid gliclazide will be used with the second matched clamp (OGTT/IGII) in visits 4 \& 5.

Trial Locations (1)

DD1 9SY

Ninewells Hospital and Medical School, Dundee

All Listed Sponsors
collaborator

NHS Tayside

OTHER_GOV

lead

University of Dundee

OTHER

NCT03705195 - Study of Sulphonylurea Synergy With Incretins | Biotech Hunter | Biotech Hunter